Nonclinical Evaluation of PF-06438179: A Potential Biosimilar to Remicade® (Infliximab).
Derzi M, Johnson TR, Shoieb AM, Conlon HD, Sharpe P, Saati A, Koob S, Bolt MW, Lorello LG, McNally J, Kirchhoff CF, Smolarek TA, Leach MW.
Derzi M, et al. Among authors: saati a.
Adv Ther. 2016 Nov;33(11):1964-1982. doi: 10.1007/s12325-016-0403-9. Epub 2016 Sep 1.
Adv Ther. 2016.
PMID: 27585978
Free PMC article.